Riskpilot← Back to searchSign inGet full accessCALLUNA PHARMA POOLCO AS
ASActiveOrg 932254638Haakon Den Godes Vei 14, 0373 OsloEconomic activity was not specified by tax authority · NACE 0000Est. 20230 employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK 1K
0 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK 2K | — |
| Net profit | NOK 1K | — |
| Total assets | NOK 387,2M | — |
| Equity | NOK 387,2M | — |
| Employees | 0 | — |
Legal name
CALLUNA PHARMA POOLCO AS
Org number
932254638
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
14. oktober 2023
Share capital
NOK 374 359
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie aksjer i calluna pharma as, herunder å realisere denne investeringen, samt all annen virksomhet knyttet til dette.
Address
Haakon Den Godes Vei 14, 0373 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 0 |
| Staff expenses | −0 |
| EBITDA | 2 |
| Depreciation & amort. | −0 |
| EBIT | 2 |
| Net financials | 0 |
| Profit before tax | 2 |
| Tax | 0 |
| Net profit | 1 |
| Item | 2024 |
|---|---|
| Total assets | 387 174 |
| Equity | 387 174 |
| Long-term debt | 0 |
| Short-term debt | 0 |
| Total debt | 0 |
EBITDA margin
150900.0%
This company
15.8%
Market median
+954963% vs market
20242024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20242024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20242024
Net profit margin
117700.0%
This company
8.1%
Market median
+1452986% vs market
20242024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20242024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-09-01 – 2024-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Sarsia Seed Fond Ii As | Company | 19.5% | 19.5% | 2024 |
Investinor Indirekte Ii As | Company | 17.5% | 17.5% | 2024 |
P53 Invest As | Company | 16.8% | 16.8% | 2024 |
Rasmussengruppen As | Company | 11.6% | 11.6% | 2024 |
Andenes Investments S.L | Company | 5.6% | 5.6% | 2024 |
Mp Pensjon Pk | Company | 5.3% | 5.3% | 2024 |
Trond Mohn Forskningsstiftelse | Company | 5.2% | 5.2% | 2024 |
Asteroidebakken As | Company | 4.1% | 4.1% | 2024 |
Sticthing Administratiekantoor Oxit | Company | 2.0% | 2.0% | 2024 |
Veen Eiendom As | Company | 1.9% | 1.9% | 2024 |
Aden As | Company | 1.8% | 1.8% | 2024 |
Sims Holding As | Company | 1.8% | 1.8% | 2024 |
Johannes Jacob Pieter Kastelein | Company | 1.2% | 1.2% | 2024 |
Tachris Ag | Company | 1.1% | 1.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CALLUNA PHARMA POOLCO AS 
Calluna Pharma AsBoard members of CALLUNA PHARMA POOLCO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanne Stuffers | Board of Directors | 0 companies |
| Birgitte Gangmark Villmo | Chairman | 0 companies |
| Sveinung Hole | Board of Directors | 0 companies |
| Kristian Brekke Djuve | Chairman | 0 companies |
| Erlend Petter Skagseth | Chairman | 0 companies |